Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet's syndrome: case series and literature review.

Jinjing LiuDong YanZhimian WangYunjiao YangShangzhu ZhangDi WuLingyi PengZhichun LiuWenjie Zheng

Published in: Therapeutic advances in musculoskeletal disease (2020)

TCZ is well tolerated and effective in severe and refractory p-NBS, with a favorable GC- and immunosuppressant-sparing effect. Cerebrospinal fluid interleukin-6 might be used to monitor the effects of TCZ in p-NBS.

Keyphrases

cerebrospinal fluid
case report
early onset
rheumatoid arthritis
robot assisted
juvenile idiopathic arthritis
rheumatoid arthritis patients
mass spectrometry
systemic lupus erythematosus
gas chromatography